Valpronate treatment during pregnancy: Description of four cases with foetal valpronate syndrome;Behandling med valproat under graviditet: Beskrivelse af fire cases med føtalt valproatsyndrom

Ugeskrift for Laeger

Volumn 171, Issue 4, 2009, Pages 221-225

  Sabers, Anne ^a   Larsen, Katja ^a   Blichfeldt, Susanne ^a   Sahlholdt, Lene ^a   Rasmussen, John Oskær ^a  

^a Epilepsihospitalet i Dianalund ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); VALPROIC ACID;

ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; EPILEPSY; FEMALE; GENETIC MARKER; GENETICS; HUMAN; MALE; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD; RISK FACTOR; SYNDROME;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; EPILEPSY; FEMALE; GENETIC MARKERS; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SYNDROME; VALPROIC ACID;

EID: 59249086791     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Holmes LB, Harvey EA, Coull BA et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344:1132-8.
2. Fried S, Kozer E, Nulman I et al. Malformation rates in children of women with untreated epilepsy. Drug Safety 2004;27:197-202.
3. Fonager KM, Larsen H, Pedersen L et al. Medfødte misdannelser og interuterin væskt hos børn eksponeret for antiepileptika in utero. Ugeskr Læger 2001;163;6279.
4. Samren EB, van Duijn CM, Koch S et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997;38:981-90.
5. Wyszynski DF, Nambisan M, Surve T et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005;64:961-5.
6. DiLiberti JH, Farndon PA, Dennis NR et al. The fetal valproate syndrome. Am J Med Genet 1984;19:473-81.
7. Jäger-Roman E, Deichl A, Jakob S et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986;108:997-1004.
8. Dalens B, Raynaud EJ, Gaulme J. Teratogenicity of valproic acid. J Pediatr 1980;97:332-3.
9. Bjerkedal T, Czeizel A, Goujard J et al. Valproic acid and spina bifida. Lancet 1982;13:1096.
10. Van der Put NM, Eskes TK, Blom HJ. Is the common 677C->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 1997;90:111-5.
11. Botto LD, Yang Q. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000;151:862-77.
12. Wald N, Sneddon J, Densem J et al. Prevention of neural tube defects: Results of the Vitamin Study Research Group. Lancet 1991;338:131-7.
13. Dean JC, Moore SJ, Osborne A et al. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet 1999;56:216-20.
14. Schneider J.A, Rees DC, Liu YT et al. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998;62;1258-60.
15. Gaily E, Kantola-Sorsa E, Hiilesmaa V et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62:28-32.
16. Isojarvi JIT, Laatikainen TJ, Pakarinen AJ et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-8.
17. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
18. Kjær D, Horvath-Puhó E, Christensen J et al. Antiepileptic drug use, folic acis, supplementation, and congenital abnormalities: a population-based case-control study. BJOG 2008;115:98-103.
19. Hendel J, Dam M, Gram L et al. The effects of carbamazepine and valproate on folate metabolism in man. Acta Neurol Scan 1984;69:226-31.
20. Friis ML, Pedersen SA, Peitersen B et al. Vejledning vedrørende behandling af gravide med epilepsi og deres børn. Ugeskr Læger 2000;162(suppl 5).